Executive Director, Contracts, Pricing & Trade

Who We Are Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering, developing and commercializing life‑changing treatments for patients with under‑addressed neurological, psychiatric, endocrine and immunological disorders. The company's diverse portfolio includes FDA‑approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in Prader‑Willi syndrome, endometriosis* and uterine fibroids*, as well as a robust pipeline including multiple compounds in mid‑to‑late‑phase clinical development across our core therapeutic areas. For more than three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science. For more information, visit neurocrine.com, and follow the company on LinkedIn, X, Facebook and YouTube. (*in collaboration with AbbVie) At Neurocrine, strong leadership drives both business results and team success. We look for leaders who think strategically, anticipate what’s ahead and set clear direction, while building and empowering high‑performing teams. Successful leaders foster an environment where people are motivated to do their best work and deliver meaningful, measurable impact through sound decision‑making and accountability. About the Role Strong strategic leader for the Contracts, Pricing & Trade function responsible for overseeing the following areas: in‑line Product Pricing, Pipeline Pricing, Payer and Channel Contracting, chargeback/rebate operations, Government Price Reporting, Gross to Net (GTN) Forecasting, NS Channel & Trade strategy and operations. Responsible for leading and operating Pricing Committee (PC) and executing pricing actions, transparency analysis and reports, and all government price reporting. Collaborates with Market Access and commercial leadership teams to drive pricing and contracting strategy leading to corresponding approaches in each channel including Payers, Third Party Logistics, Specialty Pharmacy, and Specialty Distributors. Accountable for the management and development of the contracting operations capabilities, including rebate processing and reporting systems and management of Gross to Net. Plays a crucial role in developing the government pricing strategy, reporting/compliance and Trade, Pharmacy and distribution management. Your Contributions include, but are not limited to: Government Price Calculations and Reporting Ensures compliance with government reporting requirements, including IRA impacts, as well as closely monitor changes that will impact government price reporting. Accountable for accurate and timely submissions of GP reporting obligations, including but not limited to: AMP, BP, FCP, 340B/PHS, ANFAMP, and NFAMP. Accountable for BFFS/FMV assessments as needed. Oversees the state price transparency reporting work group, and submissions. Leads Government Price Reporting and ensure processes and procedures are well‑documented. Pricing Leads and conducts pricing and payer research to support in line pricing actions and pipeline and product launches driven by an understanding and leading all aspects of payer policies and trends that impact the therapeutic area. Responsible for leading and operating Pricing Committee (PC), overseeing the administration and governance, of Pricing Committee including establishment and management of the approval process. GTN Forecasting Leads quarterly GTN review for finance to ensure accuracy of reporting. Collaborates with Finance to assess the accuracy of GTN forecast/actuals and summarize key drivers for senior leadership. Support the short‑term and long‑term forecasts and supports analysis and recommendation of both inline and upcoming launch indications/products. Leads pricing, contracting, and related discount forecasting for all access and reimbursement segments. Access Strategy, Contracting and Operations Leads the development of analytical tools and models to assess deal vs. no‑deal scenarios as it relates to contracting in the areas of (Commercial and Part D), Government (DoD, VA, State Medicaid), PBM, and long‑term care (LTC) markets. Participates in the goal-setting process for market access performance and establishes defining metrics and processes for real‑time measurement in collaboration with leadership to efficiently find opportunities for innovation. Manages the analysis, and defines pricing and contract strategy with the team for: Medicare Part D bids, Commercial, Medicaid, Federal‑VA/DoD, GPO, Long‑Term Care, and Distribution. Oversees rebate operations and 3PL provider. Trade Strategy & Operations Leads Neurocrine' s Trade and Channel strategy according to the brands objectives. Oversees #J-18808-Ljbffr neurocrine